iSpecimen Inc (ISPC)
4.34
-0.24
(-5.24%)
USD |
NASDAQ |
Nov 22, 16:00
4.34
0.00 (0.00%)
After-Hours: 16:19
iSpecimen Gross Profit Margin (Quarterly): 41.62% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 41.62% |
| June 30, 2024 | 50.26% |
| March 31, 2024 | 56.33% |
| December 31, 2023 | 44.58% |
| September 30, 2023 | 49.87% |
| June 30, 2023 | 47.47% |
| March 31, 2023 | 61.12% |
| December 31, 2022 | 52.40% |
| September 30, 2022 | 54.26% |
| June 30, 2022 | 57.25% |
| March 31, 2022 | 53.71% |
| Date | Value |
|---|---|
| December 31, 2021 | 52.05% |
| September 30, 2021 | 66.39% |
| June 30, 2021 | 48.72% |
| March 31, 2021 | 45.22% |
| December 31, 2020 | 42.84% |
| September 30, 2020 | 59.83% |
| June 30, 2020 | 68.50% |
| March 31, 2020 | 61.78% |
| December 31, 2019 | 51.87% |
| September 30, 2019 | 29.74% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
41.62%
Minimum
Sep 2024
68.50%
Maximum
Jun 2020
53.30%
Average
52.23%
Median
Gross Profit Margin (Quarterly) Benchmarks
| RadNet Inc | 15.04% |
| 23andMe Holding Co | 50.84% |
| Delcath Systems Inc | 85.36% |
| CytoSorbents Corp | 52.29% |
| Progyny Inc | 20.67% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -118.9% |
| Return on Assets | -70.24% |
| Return on Invested Capital | -116.3% |
| Profit Margin (Quarterly) | -54.09% |
| Operating Margin (Quarterly) | -64.07% |
| Return on Net Operating Assets | -97.40% |